FDAnews Announces — New Management Report — Efficient Premarket Applications: Three FDA Submission Paths That Require Less Time, Money and Effort
Falls Church, VA (PRWEB) October 02, 2017 -- To get a new medical device to market faster, devicemakers can use one of three options to bypass the lengthy clinical trial and literature search processes and get rapid FDA feedback. But which should be used: the De Novo program, Early Feasibility/First-in-Human Studies or the Expedited Access Pathway?
This report explains the criteria for each pathway, how to determine which one is right for a device and strategies for success. Fictional cases illustrate how the different pathways can be used. Readers will learn:
• The benefits and requirements of the de novo, early feasibility/first-in-human and expedited access pathways
• How to determine which pathway is the most efficient
• How the passage of the 21st Century Cures Act and the impending MDUFA goals are potential game-changers in pathway determination
• How to optimize effective communications with the FDA, depending on which pathway is best suited for a product
Efficient Premarket Applications will help save time and money in the submission process.
Who Will Benefit:
• Regulatory Affairs
• Quality Assurance
• Clinical and Medical Affairs
FDAnews Management Report Details:
Efficient Premarket Applications:
Three FDA Submission Paths That Require Less Time, Money and Effort
Price: $397
http://www.fdanews.com/products/54770-efficient-premarket-applications
Easy Ways to Order:
Online: http://www.fdanews.com/products/54770-efficient-premarket-applications
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Efficient Premarket Applications:
Three FDA Submission Paths That Require Less Time, Money and Effort
**An FDAnews Management Report**
http://www.fdanews.com/products/54770-efficient-premarket-applications
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article